Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List GSK J4 HCl

GSK J4 HCl synthesis

3synthesis methods
-

Yield:-

Reaction Conditions:

in dimethyl sulfoxide;

Steps:

Ethyl N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alaninate

Ethyl N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alaninate
To a microwave vial with a stirrer was added 2,3,4,5-tetrahydro-1H-3-benzazepine (0.049 mL, 0.326 mmol), ethyl N-[6-chloro-2-(2-pyridinyl)-4-pyrimidinyl]-β-alaninate (100 mg, 0.326 mmol), DIPEA (0.114 mL, 0.652 mmol) and Dimethyl Sulfoxide (DMSO) (0.5 mL).
The reaction vessel was sealed and heated in a Biotage Initiator microwave to 150 °C for 2.5 hr.
After allowing the reaction mixture to cool, analysis by LCMS showed 73% conversion to the product.
The reaction mixture was dissolved in DMSO to make the sample up to 1 mL and purified by MDAP. Product containing fractions were combined and the solvent evaporated in vacuo to give the title compound (99 mg) as a yellow oil.

References:

EP2592154,2013,A1 Location in patent:Page/Page column

GSK J4 HCl Related Search: